Verve Therapeutics, Inc.

NASDAQ:VERV

5.46 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -49.805-48.736-48.352-45.758-53.983-51.975-41.085-45.19-40.946-30.166-31.337-22.749-52.965-13.263-23.531-8.99-7.58-5.603
Depreciation & Amortization 1.6671.6321.5171.4741.3371.1270.9250.7170.6480.5140.4720.4120.3570.2940.2530.6240.2860.165
Deferred Income Tax 00-10.564-3.493-3.696000000.740.4120.1480.2080.1790.1350.060.006
Stock Based Compensation 11.64710.3419.2548.8259.0138.0246.7045.925.654.2032.7582.2931.3510.670.4420.2130.10.095
Change In Working Capital 5.751-4.042-2.2226.218-2.984-3.3113.2544.9097.827-7.61-0.034-2.3681.762-2.2721.7531.639-0.9540.204
Accounts Receivables 2.6860.168-2.775001.404-0.08300000000000
Change In Inventory 0000000.08300000000000
Change In Accounts Payables 3.553-3.3064.499-2.06-0.0141.4851.195-5.3944.088-5.1053.4852.061-0.6451.928-2.1981.344-0.94-0.104
Other Working Capital -0.488-0.904-3.94428.278-2.97-1.4852.05910.3033.739-2.505-3.519-4.4292.407-4.23.9510.295-0.0140.308
Other Non Cash Items 5.32414.4669.6850.9232.351-2.961-2.694.4690.063-0.448-0.6420.64536.006-0.7785.9290.0550.944-1.689
Operating Cash Flow -34.158-43.082-40.68-11.811-47.962-49.096-32.892-29.175-26.758-33.507-28.043-21.355-13.341-15.141-14.975-6.324-7.144-6.822
Investing Activities:
Investments In Property Plant And Equipment -0.98-0.433-2.185-1.061-2.662-3.375-4.968-2.637-2.719-2.908-0.981-1.002-1.306-1.07-0.953-1.022-0.396-1.053
Acquisitions Net 006.70810.773-35.687-18.767163.34552.879-10.501000000000
Purchases Of Investments -111.908-164.19-122.323-147.94-113.122-133.755-257.323-147.829-74.2490-137.004-223.3140-11.176-10.16-15.196-73.1280
Sales Maturities Of Investments 143.038122.991115.615137.167148.809152.52293.97894.9584.7563811219.79523.962313.54.5899.692
Other Investing Activites 31.13-41.199-6.708-10.77335.68718.767-163.345-52.87910.50163-56.004-211.31419.79512.78412.84-1.696-68.5399.692
Investing Cash Flow 30.15-41.632-8.893-11.83433.02515.392-168.313-55.5167.78260.092-56.985-212.31618.48911.71411.887-2.718-68.9358.639
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 1.29822.734177.38331.775-0.0651.98738.59287.9050.4450.50593.759-0.867282.90193.8310000
Common Stock Repurchased 000000000000000000
Dividends Paid 000000000000000000
Other Financing Activities 1.298-0.051-0.3930.1481.2980.0511.0080.5030.4450.505-92.535-0.867282.90193.8310.008062.88829.731
Financing Cash Flow 1.29822.734177.38331.9231.2332.03839.598288.4080.4450.5051.224-0.867282.90193.8310.008062.88829.731
Other Information:
Effect Of Forex Changes On Cash 00-15.092-3.17718.2690000000000000
Net Change In Cash -2.71-61.98127.818.278-13.704-31.666-161.607203.717-18.53127.09-83.804-234.538288.04990.404-3.08-9.042-13.19131.548
Cash At End Of Period 141.49144.2206.1883.14474.86688.57120.236281.84378.12696.65769.567153.371387.90999.869.45612.53621.57834.769